glp 1 agonist trials Real-World Evidence for GLP-1 Receptor Agonists Across the CKD Spectrum – AJKD Blog The transformative breakthroughs in GLP-1

Nogueira, J

Liraglutide slows down and sometimes even inhibits tumor growth of cancers in mice in in vivo studies

108 Another retrospective study reported that in a population with T2DM and previously diagnosed MASLD/MASH, GLP-1RA is associated with a decreased incidence of hepatocellular carcinoma (HCC) and a reduced risk of hepatic decompensation events compared with other antidiabetic agents

doi: 10.1074/jbc.M705325200 13 OakhillJSScottJWKempBE

[DOI] [PMC free article] [PubMed] [Google Scholar] 41.Chapman M.B., Norwood D.A., Price C., et al

As weight gain is a significant problem for women with breast cancer, particularly those receiving chemotherapy and endocrine therapy, safe and effective weight loss drugs for this population are urgently needed